SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-21-000258
Filing Date
2021-12-09
Accepted
2021-12-09 08:00:32
Documents
15
Period of Report
2021-12-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20211209.htm   iXBRL 8-K 39483
2 EX-99.1 exhibit991q4expectations.htm EX-99.1 10206
7 image_0.jpg GRAPHIC 27428
  Complete submission text file 0001618835-21-000258.txt   276824

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20211209.xsd EX-101.SCH 2292
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20211209_def.xml EX-101.DEF 16429
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20211209_lab.xml EX-101.LAB 31730
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20211209_pre.xml EX-101.PRE 17165
8 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20211209_htm.xml XML 14007
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 211480303
SIC: 2834 Pharmaceutical Preparations